How Wearable ECG Patches Predict Atrial Fibrillation Before It Starts

Episode 54 of The Wearable Tech Podcast dives into a quiet revolution in cardiac monitoring: continuous ECG patches that can detect atrial fibrillation days or even weeks before a symptomatic event. Lucas and Luna unpack a recent JAMA study showing that these adhesive patches, worn for up to 14 days, caught AFib in 10 percent of high-risk patients vs. just 2 percent with standard 24-hour Holter monitors. They discuss how companies like iRhythm (with its Zio patch) and newer entrants from Apple's health team are pushing toward presymptomatic detection. The conversation explores the data thresholds that trigger alerts, the false positive challenge, and what this means for the 6 million Americans living with undiagnosed AFib. Lucas argues this shift from reactive to preventive cardiac monitoring could reduce stroke risk by an order of magnitude. Luna asks the key question: are we ready to act on data our bodies haven't yet expressed as symptoms? The episode closes with a practical takeaway on who should consider an ECG patch today. No ads, just signal. #AtrialFibrillation #ECGPatch #WearableECG #iRhythm #ZioPatch #PreventiveCardiology #JAMAStudy #AFibDetection #CardiacMonitoring #ContinuousMonitoring #StrokePrevention #WearableTech #HealthTech #MedicalDevices #WearableHealth #FexingoBusiness #BusinessPodcast #Technology Keep every episode free: buymeacoffee.com/fexingo